SWA
ALXN

Sutton Wealth Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

Sutton Wealth Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,074
Closed -$197K – 1346
2021
Q2 		$197K Hold
1,074
– – 0.07% 178
2021
Q1 		$164K Buy
1,074
+5
+0.5% +$773 0.06% 187
2020
Q4 		$167K Buy
1,069
+18
+2% +$2.31K 0.07% 177
2020
Q3 		$120K Hold
1,051
– – 0.06% 196
2020
Q2 		$118K Sell
1,051
-70
-6% -$7.43K 0.06% 196
2020
Q1 		$101K Hold
1,121
– – 0.06% 192
2019
Q4 		$121K Hold
1,121
– – 0.06% 197
2019
Q3 		$110K Sell
1,121
-4
-0.4% -$451 0.06% 197
2019
Q2 		$147K Sell
1,125
-7
-0.6% -$902 0.08% 171
2019
Q1 		$153K Buy
1,132
+8
+0.7% +$995 0.09% 164
2018
Q4 		$109K Buy
1,124
+73
+7% +$8.63K 0.07% 183
2018
Q3 		$146K Sell
1,051
-2
-0.2% -$251 0.1% 157
2018
Q2 		$131K Sell
1,053
-8
-0.8% -$935 0.09% 171
2018
Q1 		$118K Buy
1,061
+5
+0.5% +$598 0.08% 180
2017
Q4 		$126K Sell
1,056
-11
-1% -$1.34K 0.09% 175
2017
Q3 		$150K Hold
1,067
– – 0.11% 153
2017
Q2 		$130K Buy
1,067
+5
+0.5% +$582 0.1% 172
2017
Q1 		$129K Sell
1,062
-5
-0.5% -$645 0.11% 158
2016
Q4 		$131K Buy
1,067
+11
+1% +$1.35K 0.12% 152
2016
Q3 		$129K Buy
1,056
+5
+0.5% +$644 0.12% 150
2016
Q2 		$123K Buy
1,051
+3
+0.3% +$426 0.12% 152
2016
Q1 		$146K Buy
+1,048
New +$154K 0.14% 130

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Sutton Wealth Advisors's ALXN Position: Q3 2021 in Review

Sutton Wealth Advisors sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 1,074 shares — an estimated $197K sold.

Sutton Wealth Advisors first reported a position in ALXN in Q1 2016 and held it in 22 quarters. The position peaked at $197K in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Sutton Wealth Advisors reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Sutton Wealth Advisors sold 1,074 Alexion Pharmaceuticals shares in Q3 2021, an estimated $197K.
  • Sutton Wealth Advisors first reported a position in Alexion Pharmaceuticals in Q1 2016 and held it in 22 quarters.
  • Sutton Wealth Advisors's Alexion Pharmaceuticals position peaked at $197K in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Sutton Wealth Advisors's 13F filing for Q3 2021, filed 7 Nov 2023.